Heat Biologics, Inc. (HTBX)’in fiyatı nedir?

Heat Biologics, Inc. (HTBX)’in fiyatı $2.38’dir

Heat Biologics, Inc. (HTBX)’in piyasa değeri nedir?

Heat Biologics, Inc. (HTBX)’in piyasa değeri $61.07M’dir.

Heat Biologics, Inc. (HTBX) Kazanç

Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.

Yıl	Kazanç	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Kazanç

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Kazanç	Kazanç Farkı	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
Moderna, Inc. MRNA.US	$-3.09B	-	US
CSL Limited CSL.AX	$1.61B	-	AU
Lonza Group AG LONN.SW	-	-	CH

Şirket

Kazanç

Kazanç Farkı

Ülke